News on 6 February 2001
A new joint venture company has been set up by Amec and
its French partner Spie to provide a broad range of services to the
pharmaceutical industry in France and other French speaking markets.
Amec Spie PharmaChem, based in Cergy Pontoise outside Paris, will bring
together Amec's global pharmaceutical expertise with Spie's engineering,
construction and maintenance services. The joint venture partners’
have worked for clients such as AstraZeneca, Merck Sharp and Dohme,
Pfizer and Sanofi-Synthelabo. It will seek to apply its knowledge and
innovative approaches early in the investment cycle, when greatest value
can be leveraged for clients.
The new company will take responsibility for planning, design, delivery
and validation of facilities for drug discovery and development, biotechnology,
production and distribution.
